Barnes PM, Adams PF, Powell-Griner E Health characteristics of the American Indian or Alaska Native adult population: United States, 2004-2008. Natl Health Stat Report. 2010 Mar 9;(20):1-22.
Carter BL, Rogers M, Daly J, Zheng S, James PA The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009 Oct 26;169(19):1748-55. doi: 10.1001/archinternmed.2009.316. Review.
Diez Roux AV Complex systems thinking and current impasses in health disparities research. Am J Public Health. 2011 Sep;101(9):1627-34. doi: 10.2105/AJPH.2011.300149. Epub 2011 Jul 21.
Eby D Integrated primary care. Int J Circumpolar Health. 1998;57 Suppl 1:665-7.
Foulds HJ, Warburton DE The blood pressure and hypertension experience among North American Indigenous populations. J Hypertens. 2014 Apr;32(4):724-34. doi: 10.1097/HJH.0000000000000084. Review.
Harris R, Nelson LA, Muller C, Buchwald D Stroke in American Indians and Alaska Natives: A Systematic Review. Am J Public Health. 2015 Aug;105(8):e16-26. doi: 10.2105/AJPH.2015.302698. Epub 2015 Jun 11. Review.
Horner RD, Day GM, Lanier AP, Provost EM, Hamel RD, Trimble BA Stroke mortality among Alaska Native people. Am J Public Health. 2009 Nov;99(11):1996-2000. doi: 10.2105/AJPH.2008.148221. Epub 2009 Sep 17. Erratum in: Am J Public Health. 2010 Feb;100(2):199.
Hutchinson RN, Shin S Systematic review of health disparities for cardiovascular diseases and associated factors among American Indian and Alaska Native populations. PLoS One. 2014 Jan 15;9(1):e80973. doi: 10.1371/journal.pone.0080973. eCollection 2014. Review.
Jolly SE, Howard BV, Umans JG Cardiovascular Disease Among Alaska Native Peoples. Curr Cardiovasc Risk Rep. 2013 Dec 1;7(6). doi: 10.1007/s12170-013-0362-5.
Kim MT, Han HR, Hedlin H, Kim J, Song HJ, Kim KB, Hill MN Teletransmitted monitoring of blood pressure and bilingual nurse counseling-sustained improvements in blood pressure control during 12 months in hypertensive Korean Americans. J Clin Hypertens (Greenwich). 2011 Aug;13(8):605-12. doi: 10.1111/j.1751-7176.2011.00479.x. Epub 2011 Jun 27.
Nasothimiou EG, Karpettas N, Dafni MG, Stergiou GS Patients' preference for ambulatory versus home blood pressure monitoring. J Hum Hypertens. 2014 Apr;28(4):224-9. doi: 10.1038/jhh.2013.104. Epub 2013 Oct 24.
Niiranen TJ, Hänninen MR, Johansson J, Reunanen A, Jula AM Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010 Jun;55(6):1346-51. doi: 10.1161/HYPERTENSIONAHA.109.149336. Epub 2010 Apr 12.
Oakes JM The (mis)estimation of neighborhood effects: causal inference for a practicable social epidemiology. Soc Sci Med. 2004 May;58(10):1929-52. Review.
Omboni S, Guarda A Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens. 2011 Sep;24(9):989-98. doi: 10.1038/ajh.2011.100. Epub 2011 Jun 9.
Stergiou GS, Christodoulakis GR, Nasothimiou EG, Giovas PP, Kalogeropoulos PG Can validated wrist devices with position sensors replace arm devices for self-home blood pressure monitoring? A randomized crossover trial using ambulatory monitoring as reference. Am J Hypertens. 2008 Jul;21(7):753-8. doi: 10.1038/ajh.2008.176. Epub 2008 Apr 24.
Zhao G, Ford ES, Mokdad AH Racial/ethnic variation in hypertension-related lifestyle behaviours among US women with self-reported hypertension. J Hum Hypertens. 2008 Sep;22(9):608-16. doi: 10.1038/jhh.2008.52. Epub 2008 May 22.
Home Blood Pressure Monitoring Intervention for Self-Management of High Blood Pressure Among Alaska Native People
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.